1 |
Loening-Baucke V, Krishna R, Pashankar DS. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 2004;39:536-9
DOI
ScienceOn
|
2 |
Youssef NN, Peters JM, Henderson W, Shultz-Peters S, Lockhart DK, Di Lorenzo C. Dose response of PEG 3350 for treatment of childhood fecal impaction. J Pediatr 2002;141: 410-4
DOI
ScienceOn
|
3 |
Loening-Baucke V. Factors responsible for persistence of childhood constipation. J Pediatr Gastroenterol Nutr 1987;6: 915-22
DOI
|
4 |
Chung KS. Chronic constipation in children. Korean J Pediatr 2004;47(3 suppl):631S-42S
|
5 |
Gremse DA, Hixon J, Crutchfield A. Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr 2002;41:225-9
DOI
|
6 |
Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Makel W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-4
DOI
ScienceOn
|
7 |
van Ginkel R, Reitsma JB, Buller HA, van Wijk MP, Taminiau JA, Benninga MA. Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 2003;125: 357-63
DOI
ScienceOn
|
8 |
Canning DA. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Urol 2003;170:327
|
9 |
Loening-Baucke V. Factors determining outcome in children with chronic constipation and faecal soiling. Gut 1989;30:999-1006
DOI
|
10 |
Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999;45(Suppl 2):60-8
|
11 |
Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, et al. Double-Blind randomized evaluation of clinical and biological tolerance of Polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005;41:625-33
DOI
ScienceOn
|
12 |
Lewis G, Rudolph CD. Practical approach to defecation disorders in children. Pediatr Ann 1997;26:260-8
DOI
|
13 |
Pashankar D, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediar Gastroenterol Nutr 2001;139: 428-32
|
14 |
Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002;34:372-7
DOI
ScienceOn
|
15 |
Hudziak H, Bronowicki JP, Frank P, Dubos-Berogin C, Bigard MA. Low dose of Polyethylene glycol 4000: digestive effects. Randomazed double-blind study in healthy subjects. Gastroenterol Clin Biol 1996;20:418-23
|
16 |
Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, et al. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999;28:612-26
|
17 |
Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of Polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. J pediatr 2006;118:528-35
DOI
ScienceOn
|
18 |
Attar A, Lemann M, Ferguson A, Halphen M, Boutron MC, Flourie B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999;44:226-30
DOI
ScienceOn
|
19 |
Benninga MA, Voskuijl WP, Taminiau JA. Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004;39:448-64
DOI
ScienceOn
|
20 |
DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95:446-50
DOI
ScienceOn
|
21 |
Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE+E) followed by a double-blind comparison of PEG+E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr 2006;43:65-70
DOI
ScienceOn
|
22 |
de Lorijn F, van Wijk MP, Reitsma JB, van Ginkel R, Taminiau JA, Benninga MA. Prognosis of constipation: clinical factors and colonic transit time. Arch Dis Child 2004;89:723-7
DOI
ScienceOn
|
23 |
Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9
DOI
ScienceOn
|
24 |
Dupont C, Leluyer B, Amar F, Kalach N, Benhamou PH, Mouterde O, et al. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr 2006;42: 178-85
DOI
ScienceOn
|
25 |
Voskuijl WP, Heijmans J, Heijmans HS, Taminiau JA, Benninga MA. Use of Rome II criteria in childhood defecation disorders: applicability in clinical and research practice. J Pediatr 2004;145:213-7
DOI
ScienceOn
|